跳至主要内容
临床试验/JPRN-UMIN000039079
JPRN-UMIN000039079已完成未知

Effect of empagliflozin 12 months after drug eluting stent implantation in type 2 diabetics with stable angina. - Effect of empagliflozin after drug eluting stent implantation in type 2 diabetics.

Department of Cardiology, NTT Medical Center Tokyo0 个研究点目标入组 30 人开始时间: 2020年1月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Use of SGLT-2 inibitor at baseline Use of insulin Patients with moderate or severe chronic kidney disease (eGFR <45) Patients with ST elevated myocardial infarction, chronic total occlusion, significant left main lesion, in-stent restenosis lesion Endocrine and gastrointestinal disorders Hepatic dysfunction (Child-Pugh score > 10) Patients with malignancy Patients with type 1 diabetes

研究者

发起方
Department of Cardiology, NTT Medical Center Tokyo

相似试验